What Chemed Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 6 | 13 |
| Total trades | 16 | 50 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 50 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lee Spencer S | executive vice president | Sep 30 | Withheld — tax / exercise cost · F | −11,160 | $508.93 | −$5.68M | 14,851 |
| Lee Spencer S | executive vice president | Sep 30 | Exercise / conversion · M | +12,099 | $445.35 | +$5.39M | 26,011 |
| Mcnamara Kevin J | president and CEO | Sep 28 | Open-market sale · S | −2,000 | $513.45 | −$1.03M | 66,418 |
| Hutton Thomas C | vice president | Sep 28 | Withheld — tax / exercise cost · F | −4,270 | $506.65 | −$2.16M | 32,840 |
| Hutton Thomas C | vice president | Sep 28 | Exercise / conversion · M | +4,629 | $445.35 | +$2.06M | 37,110 |
| Mcnamara Kevin J | president and CEO | Sep 18 | Open-market sale · S | −2,000 | $501.40 | −$1M | 68,418 |
| Lee Spencer S | executive vice president | Aug 21 | Open-market sale · S | −1,000 | $541.04 | −$541K | 13,912 |
| Mcnamara Kevin J | president and CEO | Aug 21 | Open-market sale · S | −2,000 | $541.16 | −$1.08M | 70,418 |
| Judkins Brian C | VP and Chief Legal Officer | Aug 10 | Withheld — tax / exercise cost · F | −5,878 | $548.96 | −$3.23M | 3,344 |
| Judkins Brian C | VP and Chief Legal Officer | Aug 10 | Exercise / conversion · M | +6,786 | $445.35 | +$3.02M | 9,222 |
| Wherley Joel L | CEO - Vitas Healthcare | Aug 05 | Withheld — tax / exercise cost · F | −2,270 | $542.62 | −$1.23M | 1,181 |
| Wherley Joel L | CEO - Vitas Healthcare | Aug 05 | Exercise / conversion · M | +2,599 | $445.35 | +$1.16M | 3,451 |
| Mcnamara Kevin J | president and CEO | Aug 03 | Open-market sale · S | −2,000 | $539.51 | −$1.08M | 70,418 |
| Grace Patrick P | Director | Jul 31 | Open-market sale · S | −190 | $532.00 | −$101K | 3,533 |
| Mcnamara Kevin J | president and CEO | Jul 31 | Withheld — tax / exercise cost · F | −19,802 | $529.22 | −$10.5M | 72,418 |
| Mcnamara Kevin J | president and CEO | Jul 31 | Exercise / conversion · M | +2,001 | $445.35 | +$891K | 92,220 |
| Lindell Andrea R | Director | Jun 09 | Open-market sale · S | −1,347 | $447.33 | −$603K | 4,578 |
| Walsh George J Iii | Director | May 29 | Open-market sale · S | −500 | $437.83 | −$219K | 3,209 |
| DeLyons Ron | Director | May 18 | Grant / award · A | +386 | $440.77 | +$170K | 2,052 |
| Grace Patrick P | Director | May 18 | Grant / award · A | +386 | $440.77 | +$170K | 3,723 |
Loading...
